The MOXO wearable was originally developed to study the stress levels of children who have autism. That device, commercialized through MIT professor Rosalind Picard’s startup Empatica, was developed into the E4 wristband that can sense when a seizure is going to occur.
Now, Denver-based mPath is using its sensor to help bring market research insights to companies to help improve their product offerings. The device is designed to pinpoint subconscious responses to different stimulants, like if a consumer gets excited about a certain product or is bored by a performance.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.